A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals

Objectives: HIV-1-specific CD8 T cells are considered to be critical in ant i-HIV responses. It is important to quantify these cells and to determine t heir antigenic targets. Here quantification of interferon (IFN)-gamma secre ting, virus-specific cells was achieved with an enzyme linked immune spot ( ELISPOT) assay. Methods: Peripheral blood mononuclear cells (PBMC) were infected with recom binant vaccinia Vectors expressing HIV-1 genes (gag, pol, env or nef) and a dded to wells precoated with anti-IFN-gamma monoclonal antibodies. Spot for ming cells (SFC), i.e. antigen-specific T cells were detected 24 h later by the addition of biotinylated anti-IFN-gamma monoclonal antibodies, followe d by avidin-bound biotinylated horseradish peroxidase. Results: In a cohort of 19 patients, of whom 15 were on highly active antir etroviral therapy, 18 had primed T cells directed against one or more HIV-I antigens (P < 0.0001). Pol-specific T cells routinely dominated the CD8 re sponse with frequencies up to 2000 SFC per 10(6) PBMC. In HLA A*0201-positi ve patients, the vaccinia vectors detected much higher frequencies of SFC t han haplotype-restricted peptides. Elimination of CD8 T cells resulted in > 90% loss of antigen-specific SFC when vaccinia virus was used as a vector. The number of CD8 SFC exceeded the number of memory cells detected in limi ting dilution assays by > 1 log(10), whereas a correlation was found betwee n the frequency of effector cells detected by both ELISPOT and MHC class I peptide tetramer assays. Conclusions: Vaccinia Virus vectors used in ELISPOT assays are useful for d etermining the frequency and specificity of CD8 T cells for individual HIV- 1 gene products. The dominance of cytolytic T lymphocytes (CTL) recognizing pol proteins suggests that this antigen should be considered in vaccine st rategies. (C) 1999 Lippincott Williams & Wilkins.